Chi-Jen Chu

Prevalence of HBV precore/core promoter variants in the United States (2003)

Chu, Chi-Jen, Keeffe, Emmet B., Han, Steven-Huy, Perrillo, Robert P., Min, Albert D., Soldevila-Pico, Consuelo, ...

Variants in the precore (G 1896 A) and core promoter (A 1762 T, G 1764 A) regions of hepatitis B virus (HBV) may be related to serum HBV DNA levels and severity of liver disease. The aims of this...

Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection (2002)

Chu, Chi-Jen, Hussain, Munira, Lok, Anna S. F.

The goals of this retrospective study were to determine whether there is a threshold hepatitis B virus (HBV) DNA value associated with spontaneous or antiviral therapy–related hepatitis B e antigen...

HBV genotype B is associated with better response to interferon therapy in HBeAg(+) chronic hepatitis than genotype C (2002)

Wai, Chun Tao, Chu, Chi-Jen, Hussain, Munira, Lok, Anna S. F.

Hepatitis B virus (HBV) genotype and precore/core promoter mutations have been implicated in spontaneous and interferon alfa (IFN-Α)–related hepatitis B e antigen (HBeAg) seroconversion. We...

Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection (2002)

Chu, Chi-Jen, Hussain, Munira, Lok, Anna Suk-Fong

The goals of this retrospective study were to determine whether there is a threshold hepatitis B virus (HBV) DNA value associated with spontaneous or antiviral therapy—related hepatitis B e antigen...

HBV genotype B is associated with better response to interferon therapy in HBeAg( + ) chronic hepatitis than genotype C (2002)

Wai, Chun-Tao, Chu, Chi-Jen, Hussain, Munira, Lok, Anna Suk-Fong

Hepatitis B virus (HBV) genotype and precore/core promoter mutations have been implicated in spontaneous and interferon alfa (IFN-Α)—related hepatitis B e antigen (HBeAg) seroconversion. We...

Clinical significance of hepatitis B virus genotypes (2002)

Chu, Chi-Jen, Lok, Anna Suk-Fong

No Abstract.

Outcome of liver transplantation for hepatitis B: Report of a single center's experience (2001)

Chu, Chi-Jen, Fontana, Robert J., Moore, Charles, Armstrong, Douglas R., Punch, Jeffrey D., Su, Grace L., ...

Results of liver transplantation (LT) for hepatitis B have improved significantly with the use of hepatitis B immune globulin (HBIG) and/or lamivudine. The aim of this study is to review the...

Does OKT3 increase the risk of recurrent hepatitis B in patients transplanted for hepatitis B? (2000)

Chu, Chi-Jen, Lok, Anna Suk-Fong

No Abstract.

Rapid and Sensitive Assays for Determination of Hepatitis B Virus (HBV) Genotypes and Detection of HBV Precore and Core Promoter Variants

Hussain, Munira, Chu, Chi-Jen, Sablon, Erwin, Lok, Anna S. F.

Hepatitis B virus (HBV) genotypes may influence HBeAg seroconversion rates, mutational patterns in the precore (PC) and core promoter (CP) regions, severity of liver disease, and response to...

Rapid and Sensitive Assays for Determination of Hepatitis B Virus (HBV) Genotypes and Detection of HBV Precore and Core Promoter Variants

Hussain, Munira, Chu, Chi-Jen, Sablon, Erwin, Lok, Anna S. F.

Hepatitis B virus (HBV) genotypes may influence HBeAg seroconversion rates, mutational patterns in the precore (PC) and core promoter (CP) regions, severity of liver disease, and response to...

Low risk of hepatitis B virus recurrence after withdrawal of long-term hepatitis B immunoglobulin in patients receiving maintenance nucleos(t)ide analogue therapy

Wong, Stephen N., Chu, Chi-Jen, Wai, Chun-Tao, Howell, Terese, Moore, Charles, Fontana, Robert J., ...

Hepatitis B virus (HBV) recurrence rates of 0-16% had been reported in patients maintained on nucleoside analogues (NA) after hepatitis B immunoglobulin (HBIG) discontinuation after orthotopic liver...